Bringing the fundamentals into focus…
Back to Takeda Pharmaceutical Company Limited
How Takeda Pharmaceutical Company Limited stacks up
TAK · against 1,216 other Healthcare companies
Growth
20/ 100
Near the bottom of its peers.
Ranked #968 of 1,217 · scores higher than 20% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including TAK · Click a bar to see the companies
Why growth scores 20?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 73% of peers. Revenue growth: -1.7% vs peer median 6.1%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 3.8% vs peer median 5.8%
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = TAK, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TAK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -1.7% | 6.1% | 27% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 78.0% | 9.7% | 83% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 3.8% | 5.8% | 41% | 33% |
Ranking by growth score
Top 5 and the companies ranked around TAK| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 968 | 36.8B USD | 20 | 46 | |
| 968 | 22.3B SEK (≈$2.2B) | 20 | 36 | |
| 968 | 1.91T IDR (≈$119M) | 20 | 26 | |
| 968 | 356.9B USD | 20 | 37 | |
| 968 | 66.3B USD | 20 | 30 | |
| 968 | 705M USD | 20 | 32 | |
| 980 | 7.2B CNY (≈$1.0B) | 19 | 61 | |
| 980 | 3.9B CNY (≈$543M) | 19 | 49 | |
| 980 | 5.9B HKD (≈$757M) | 19 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score